Advertisement

The Indian Journal of Pediatrics

, Volume 85, Issue 5, pp 339–343 | Cite as

Familial Hypercholesterolemia: Cascade Screening in Children and Relatives of the Affected

  • Nitika Setia
  • Renu Saxena
  • J. P. S. Sawhney
  • Ishwar C. Verma
Original Article

Abstract

Objective

Familial Hypercholesterolemia (FH) is an inherited disorder of lipid metabolism characterized by very high low density lipoprotein (LDL) cholesterol since birth, resulting in premature atherosclerosis and coronary artery disease (CAD). Cascade screening of children and family members of proven FH individuals can identify more subjects who have high LDL cholesterol or the family mutation and appropriate intervention can reduce their risk of atherosclerosis and prevent its complications.

Methods

Cascade screening by molecular testing, was carried out in 133 family members, comprising 24 children, of 31 probands with FH having a pathogenic mutation in LDLR/ApoB gene. Lipid profiles were obtained in 44 family members including 11 children.

Results

Of 133 family members tested, 88 (66.1%) were identified to carry the family mutation. Twelve of these were children below 18 y of age and 76 were adults. CAD was present in 15 (11.2%) family members and 63(47.4%) family members, including nine children, were already on Lipid Lowering Therapy.

Conclusions

Cascade screening led to identification of 88 new cases, with a pathogenic mutation, who were at a very high risk of developing premature CAD. The authors identified 12 children with family specific mutation, out of which 9 were initiated on low dose statin therapy. Four homozygous children were treated with high dose statins because of substantially increased risk of CAD. Cascade screening, therefore, proved to be a successful initiative towards primary prevention of CAD in India.

Keywords

Familial hypercholesterolemia Cascade screening Children Genetic testing 

Notes

Acknowledgements

The authors acknowledge the cardiologists and physicians from various states of India for referring the cases to Institute of Medical Genetics and Genomics, Sir Ganga Ram hospital, New Delhi. They are thankful to all their patients and family members for providing them with important information and blood samples for genetic studies. The authors extend their thanks to SGRH and ICMR for financial assistance.

Contributions

ICV was involved in conceiving the idea, initial study design and critical evaluation of the manuscript. RS helped with study design, technical troubleshooting and manuscript evaluation. JPS was involved in patient referrals and management. NS was involved in data acquisition, molecular studies, data analysis and manuscript preparation. ICV will act as guarantor for this paper.

Compliance with Ethical Standards

Conflict of Interest

None.

Source of Funding

The study has been funded by Research Development Program, Sir Ganga Ram Hospital (Grant No: EC/10/10/197; 4.9.13) and Indian Council of Medical Research (Sanction No: 54/16/2011-BMS).

References

  1. 1.
    McCrindle BW, Kwiterovich PO, McBride PE, Daniels SR, Kavey RE. Guidelines for lipid screening in children and adolescents: bringing evidence to the debate. Pediatrics. 2012;130:353–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Goldberg AC, Hopkins PN, Toth PP, et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011;5:133–40.CrossRefPubMedGoogle Scholar
  3. 3.
    Wiegman A, Gidding SS, Watts GF, et al; European atherosclerosis society consensus panel. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015;36:2425–37.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int J Cardiol. 2014;171:309–25.CrossRefPubMedGoogle Scholar
  5. 5.
    Iyengar SS, Puri R, Narasingan SN, Wangnoo SK, Mohan V, Mohan JC. Lipid Association of India Expert Consensus Statement on management of dyslipidemia in Indians 2016: part 1. J Assoc Physicians India. 2016;64:7–52.PubMedGoogle Scholar
  6. 6.
    Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolaemia: a HuGE prevalence review. Am J Epidemiol. 2004;160:407–20.CrossRefPubMedGoogle Scholar
  7. 7.
    EAS Familial Hypercholesterolaemia Studies Collaboration, Vallejo-Vaz AJ, Akram A, Kondapally Seshasai SR, Cole D, Watts GF. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. Atheroscler Suppl. 2016;22:1–32.CrossRefGoogle Scholar
  8. 8.
    Puri S, Puri S, Rehan HS, et al. Prevalence and pattern of dyslipidemia in 2500 adolescents in suburban india. J Am Coll Cardiol. 2015;65:A1486.CrossRefGoogle Scholar
  9. 9.
    Stoekenbroek RM, Kastelein JJP, Hovingh GK. Can we afford not to screen for FH? Eur Heart J. 2017;0:1–3.  https://doi.org/10.1093/eurheartj/ehx197.Google Scholar
  10. 10.
    Ademi Z, Watts GF, Pang J, et al. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia. J Clin Lipidol. 2014;8:390–400.CrossRefPubMedGoogle Scholar
  11. 11.
    Louter L, Defesche J, Roeters van Lennep J. Cascade screening for familial hypercholesterolemia: practical consequences. Atheroscler Suppl. 2017;30:77–85.  https://doi.org/10.1016/j.atherosclerosissup.2017.05.019.
  12. 12.
    Humphries SE, Neil AD. Developing and applying clinically useful approaches to identify individuals with familial hypercholesterolemia in the UK. Clin Lipidol. 2010;5:497–507.CrossRefGoogle Scholar
  13. 13.
    Newson AJ, Humphries SE. Cascade testing in familial hypercholesterolaemia: how should family members be contacted? Eur J Hum Genet. 2005;13:401–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Setia N, Saxena R, Arora A, Verma IC. Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations. Atherosclerosis. 2016;255:31–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Starr B, Hadfield G, Hutton BA, et al. Development of sensitive and specific age-and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first degree relatives with familial hypercholesterolaemia in cascade testing. Clin Chem Lab Med. 2008;46:791–803.CrossRefPubMedGoogle Scholar
  17. 17.
    Humphries SE, Norbury G, Leigh S, Hadfield SG, Nair D. What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia? Curr Opin Lipidol. 2008;19:362–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Watts GF, Sullivan DR, Poplawski N, et al. Familial hypercholesterolaemia: a model of care for Australasia. Atheroscler Suppl. 2011;12:221–63.CrossRefPubMedGoogle Scholar
  19. 19.
    Daniels SR, Greer FR; Committee on nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122:198–208.CrossRefPubMedGoogle Scholar
  20. 20.
    Eiland LS, Luttrell PK. Use of statins for dyslipidemia in the pediatric population. J Pediatr Pharmacol Ther. 2010;15:160–72.PubMedPubMedCentralGoogle Scholar
  21. 21.
    DeMott K, Nherera L, Shaw EJ, Minhas R, Humphries SE, Kathoria M. Clinical guidelines and evidence review for familial hypercholesterolaemia: the identification and management of adults and children with familial hypercholesterolaemia. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2008.Google Scholar
  22. 22.
    Martin AC, Gidding SS, Wiegman A, Watts GF. Knowns and unknowns in the care of pediatric familial hypercholesterolemia. J Lipid Res. 2017;58:1765–76.CrossRefPubMedGoogle Scholar
  23. 23.
    Wald DS, Kasturiratne A, Godoy A, et al. Child-parent screening for familial hypercholesterolemia. J Pediatr. 2011;159:865–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Wald DS, Bestwick JP, Wald NJ. Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis. BMJ. 2007;335:599.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Taylor A, Wang D, Patel K, et al. Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project. Clin Genet. 2010;77:572–80.CrossRefPubMedGoogle Scholar
  26. 26.
    Knowles JW, Rader DJ, Khoury MJ. Cascade screening for familial hypercholesterolemia and the use of genetic testing. JAMA. 2017;318:381–2.CrossRefPubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2018

Authors and Affiliations

  • Nitika Setia
    • 1
  • Renu Saxena
    • 1
  • J. P. S. Sawhney
    • 2
  • Ishwar C. Verma
    • 1
  1. 1.Institute of Medical Genetics and Genomics, Sir Ganga Ram HospitalNew DelhiIndia
  2. 2.Department of CardiologySir Ganga Ram HospitalNew DelhiIndia

Personalised recommendations